BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 199 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $80,000 | +19.4% | 5,019 | -20.6% | 0.00% | – |
| Q2 2022 | $67,000 | -35.0% | 6,321 | 0.0% | 0.00% | – |
| Q1 2022 | $103,000 | -10.4% | 6,321 | -23.9% | 0.00% | – |
| Q4 2021 | $115,000 | +23.7% | 8,305 | +27.7% | 0.00% | – |
| Q3 2021 | $93,000 | -31.6% | 6,502 | -24.4% | 0.00% | – |
| Q2 2021 | $136,000 | +60.0% | 8,605 | +3.0% | 0.00% | – |
| Q1 2021 | $85,000 | +14.9% | 8,352 | -15.9% | 0.00% | – |
| Q4 2020 | $74,000 | +117.6% | 9,932 | 0.0% | 0.00% | – |
| Q3 2020 | $34,000 | +6.2% | 9,932 | +47.5% | 0.00% | – |
| Q2 2020 | $32,000 | +255.6% | 6,732 | +274.0% | 0.00% | – |
| Q4 2017 | $9,000 | -87.5% | 1,800 | -92.9% | 0.00% | – |
| Q1 2016 | $72,000 | -95.0% | 25,529 | -81.7% | 0.00% | -100.0% |
| Q4 2015 | $1,437,000 | -8.3% | 139,248 | +1.3% | 0.00% | 0.0% |
| Q3 2015 | $1,567,000 | -7.7% | 137,442 | +21.0% | 0.00% | 0.0% |
| Q2 2015 | $1,697,000 | +70.2% | 113,635 | +2.9% | 0.00% | +50.0% |
| Q1 2015 | $997,000 | -42.3% | 110,392 | -22.4% | 0.00% | -50.0% |
| Q4 2014 | $1,729,000 | +79.4% | 142,167 | +44.3% | 0.00% | +100.0% |
| Q3 2014 | $964,000 | +121.6% | 98,551 | +189.0% | 0.00% | +100.0% |
| Q2 2014 | $435,000 | – | 34,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |